These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 22297765)

  • 1. Lorazepam 0.25 mg twice a day improves aspects of psychometric performance in healthy volunteers.
    Bourin M; Colombel MC; Malinge M
    J Psychopharmacol; 1995 Jan; 9(3):251-7. PubMed ID: 22297765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the interaction between a partial agonist and a full agonist of benzodiazepine receptors, based on psychomotor performance and memory, in healthy volunteers.
    Patat A; Perault MC; Vandel B; Danjou P; Brohier S; Zieleniuk I; Rosenzweig P
    J Psychopharmacol; 1995 Jan; 9(2):91-101. PubMed ID: 22298734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alprazolam 0.125 mg twice a day improves aspects of psychometric performance in healthy volunteers.
    Bourin M; Colombel MC; Guitton B
    J Clin Psychopharmacol; 1998 Oct; 18(5):364-72. PubMed ID: 9790153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cognitive and psychomotor effects of nisoldipine or placebo in healthy volunteers.
    Ponciano E; Robinson L; Barreto M; Cockle SM; Hindmarch I
    Hum Psychopharmacol; 2000 Mar; 15(2):137-142. PubMed ID: 12404341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of low doses of lorazepam on psychometric tests in healthy volunteers.
    Bourin M; Couëtoux du Tertre A; Colombel MC; Auget JL
    Int Clin Psychopharmacol; 1994; 9(2):83-8. PubMed ID: 8056998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative cognitive and psychomotor effects of single doses of Valeriana officianalis and triazolam in healthy volunteers.
    Hallam KT; Olver JS; McGrath C; Norman TR
    Hum Psychopharmacol; 2003 Dec; 18(8):619-25. PubMed ID: 14696021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychomotor performance in healthy young adult volunteers receiving lormetazepam and placebo: a single-dose, randomized, double-blind, crossover trial.
    Fabbrini M; Frittelli C; Bonanni E; Maestri M; Manca ML; Iudice A
    Clin Ther; 2005 Jan; 27(1):78-83. PubMed ID: 15763608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of risperidone on psychometric and cognitive functions in healthy elderly volunteers.
    Allain H; Tessier C; Bentué-Ferrer D; Tarral A; Le Breton S; Gandon M; Bouhours P
    Psychopharmacology (Berl); 2003 Feb; 165(4):419-29. PubMed ID: 12459926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sedation and memory: studies with a histamine H-1 receptor antagonist.
    Turner C; Handford AD; Nicholson AN
    J Psychopharmacol; 2006 Jul; 20(4):506-17. PubMed ID: 16401664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acute and chronic performance effects of alprazolam and lorazepam in the elderly: relationship to duration of treatment and self-rated sedation.
    Pomara N; Tun H; DaSilva D; Hernando R; Deptula D; Greenblatt DJ
    Psychopharmacol Bull; 1998; 34(2):139-53. PubMed ID: 9640992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of paroxetine, alone and in combination with alcohol on psychomotor performance and cognitive function in the elderly.
    Kerr JS; Fairweather DB; Mahendran R; Hindmarch I
    Int Clin Psychopharmacol; 1992 Nov; 7(2):101-8. PubMed ID: 1487621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of ipsapirone treatment compared with lorazepam: discontinuation effects.
    Busto UE; Naranjo CA; Bremner KE; Peachey JE; Bologa M
    J Psychiatry Neurosci; 1998 Jan; 23(1):35-44. PubMed ID: 9505058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance impairment and increased anxiety resulting from the combination of alcohol and lorazepam.
    Lister RG; File SE
    J Clin Psychopharmacol; 1983 Apr; 3(2):66-71. PubMed ID: 6132935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of single and repeated administration of ebastine on cognition and psychomotor performance in comparison to triprolidine and placebo in healthy volunteers.
    Hindmarch ; Shamsi Z
    Curr Med Res Opin; 2001; 17(4):273-81. PubMed ID: 11922401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual effects of zaleplon and zolpidem following middle of the night administration five hours to one hour before awakening.
    Hindmarch I; Patat A; Stanley N; Paty I; Rigney U
    Hum Psychopharmacol; 2001 Mar; 16(2):159-167. PubMed ID: 12404586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of a single oral dose of lorazepam and alprazolam on reaction times in young healthy volunteers.
    Crombez G; Kupers R; Adriaensen H
    Acta Anaesthesiol Belg; 1991; 42(2):79-84. PubMed ID: 1927238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of repeated doses of temazepam taken in conjunction with alcohol on aspects of psychomotor performance the morning following night time medication.
    Hindmarch I
    Arzneimittelforschung; 1978; 28(12):2357-60. PubMed ID: 40572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between effects of caffeine and lorazepam in performance tests and self-ratings.
    File SE; Bond AJ; Lister RG
    J Clin Psychopharmacol; 1982 Apr; 2(2):102-6. PubMed ID: 6122694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The psychopharmacological effects of Ginkgo biloba extract in normal healthy volunteers.
    Subhan Z; Hindmarch I
    Int J Clin Pharmacol Res; 1984; 4(2):89-93. PubMed ID: 6469442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of the psychomotor and antistress effects of ritanserin, alprazolam and diazepam in healthy subjects: some trait anxiety-independent responses.
    Danjou P; Warot D; Hergueta T; Lacomblez L; Bouhours P; Puech AJ
    Int Clin Psychopharmacol; 1992 Nov; 7(2):73-9. PubMed ID: 1487624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.